We are live on ! Find out more

HNGE

Hinge Health

HNGE

Market cap $7.05B

87.35 USD

-5.50

5.92%

At close Updated Aug 28, 4:00 PM EDT

Pre-market

After hours

86.24

-1.11

1.27%

1 day

-5.92%

5 days

-1.21%

1 month

16.08%

3 months

58.96%

6 months

94.72%

Year to date

91.73%

1 year

51.31%

5 years

132.56%

10 years

132.56%

About: Hinge Health Inc is a technology platform for individuals seeking to treat and prevent joint and muscle pain. Through a combination of AI-powered motion tracking technology, the Company's platform helps members address chronic musculoskeletal (MSK) conditions, enables improved member outcomes and supports cost reductions for its clients.

Employees: 1,437

Healthcare Health Information Services

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 52.8%

Neutral 41.7%

Negative 5.6%

Investors Business Daily

Hinge Health Catapults 95%; Expands Footprint In AI Pain Management

Pain management mobile program provider Hinge Health is in a buy zone above a 93.13 pivot

Hinge Health Catapults 95%; Expands Footprint In AI Pain Management

Investors Business Daily

IPO Stock Of The Week: Hinge Health Finds Support At Key Level, Eyes New Buy Points

Hinge stock found support at a key level in recent weeks and is approaching multiple new buy points despite market weakness.

IPO Stock Of The Week: Hinge Health Finds Support At Key Level, Eyes New Buy Points

One Platform, Every Ailment: Hinge Health's Gamble

Many people know that seemingly unrelated symptoms can be connected. But in most cases, treating individual symptoms means a separate doctor visit, sometimes to different specialists, before the full picture emerges.

One Platform, Every Ailment: Hinge Health's Gamble

Zacks Investment Research

HNGE Stock Surges Nearly 90% YTD: Can Its Growth Story Continue?

Hinge Health's nearly 90% YTD surge is backed by 53% revenue growth, wider margins and expansion into migraine and GI care, but execution risks remain.

HNGE Stock Surges Nearly 90% YTD: Can Its Growth Story Continue?

Zacks Investment Research

Reasons to Hold Hinge Health Stock in Your Portfolio for Now

HNGE's strong revenue growth, raised 2026 outlook and expansion into Migraine and GI care support its growth prospects despite investment pressures.

Reasons to Hold Hinge Health Stock in Your Portfolio for Now

Zacks Investment Research

Is Hinge Health Stock a Buy as Growth Accelerates and Risks Rise?

HNGE's rapid revenue growth, widening margins and higher 2026 outlook strengthen its case, but expansion raises execution risks.

Is Hinge Health Stock a Buy as Growth Accelerates and Risks Rise?

Zacks Investment Research

Hinge Health's Cylinder Deal Opens a $135B GI Care Growth Opportunity

HNGE's $105 million Cylinder deal opens a $135 billion GI care market, adding nearly 100 clients and about 2 million lives.

Hinge Health's Cylinder Deal Opens a $135B GI Care Growth Opportunity

Zacks Investment Research

HNGE Rallies 64.6% in 3 Months as Growth and Margins Gain Momentum

Hinge Health 64.6% three-month rally is backed by surging revenues, wider margins and a raised 2026 outlook, but execution expectations are rising.

HNGE Rallies 64.6% in 3 Months as Growth and Margins Gain Momentum

Zacks Investment Research

Is the Options Market Predicting a Spike in Hinge Health Stock?

Investors need to pay close attention to HNGE stock based on the movements in the options market lately.

Is the Options Market Predicting a Spike in Hinge Health Stock?

Jim Cramer Recommends Buying This Health Care Stock: ‘What A Quarter They Had'

On CNBC's “Mad Money Lightning Round,” Jim Cramer said Hinge Health, Inc. (NYSE:HNGE) is a buy. “What a quarter they had,” he added.

Jim Cramer Recommends Buying This Health Care Stock: ‘What A Quarter They Had'

See News Rankings

Price charts implemented using Lightweight Charts™